BG
IDIX

Baupost Group’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Baupost Group’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-53,331,109
Closed -$1.27B – 28
2014
Q2 		$1.27B Hold
53,331,109
– – 20.67% 2
2014
Q1 		$303M Buy
53,331,109
+16,420,241
+44% +$115M 7.32% 5
2013
Q4 		$221M Buy
36,910,868
+7,245,175
+24% +$33.5M 6.25% 5
2013
Q3 		$154M Buy
29,665,693
+2,898,693
+11% +$12.7M 4.4% 5
2013
Q2 		$96.6M Buy
+26,767,000
New +$109M 2.4% 7

Baupost Group's IDIX Position: Q3 2014 in Review

Baupost Group sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 53,331,109 shares — an estimated $1.27B sold.

Baupost Group first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $1.27B in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • Baupost Group reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Baupost Group sold 53,331,109 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $1.27B.
  • Baupost Group first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
  • Baupost Group's IDENIX PHARMACEUTICALS INC position peaked at $1.27B in Q2 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Baupost Group's 13F filing for Q3 2014, filed 14 Nov 2014.